TCEB3 Antibody from FORTIS LIFE SCIENCES
Search, find, compare suppliers for anti-TCEB3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TCEB3 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 10 µl |
| Concentration | 200 µg/ml |
| Applications | WB, IP |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Rabbit anti-TCEB3 Antibody, Affinity Purified. Transcription elongation factor B polypeptide 3 (TCEB3), also known as Elongin A, was identified as a factor that could increase the catalytic rate of Pol II transcription elongation. Transcription elongation is one step in the multistage process of transcription that involves the polymerization of nucleoside monophosphates into a ribonucleotide transcript catalyzed by Pol II. Successful elongation requires factors that promote sufficient elongation rates and processivity. TCEB3 or Elongin A is part of a heterotrimeric complex, Elongin (SIII) that includes Elongin A, B, and C and facilitates transcription elongation by suppressing transient pausing by Pol II. |
| Immunogen | Epitope: between 325 and 375 |
| Other Names | TCEB3; transcription elongation factor B subunit 3; transcription elongation factor B polypeptide 3; TCEB3A; transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A); SIII; SIII p110; RNA polymerase II transcription factor SIII subunit A1; elongin-A; elongin 110 kDa subunit; EloA; transcription elongation factor B alpha subunit |
| Gene, Accession # | Gene ID: 6924, Accession: NP_003189.1, UniProt: Q14241 |
| Catalog # | A300-942A-T |
| Price | $121 |
| Order / More Info | TCEB3 Antibody from FORTIS LIFE SCIENCES |
| Product Specific References | n/a |
FORTIS LIFE SCIENCES
FORTIS LIFE SCIENCES
1440 Main Street, Suite 300
Waltham MA 02451
P: 800.338.9579
info@fortislife.com
https://www.fortislife.com
Profile of FORTIS LIFE SCIENCES
Return to Antibodies